Home › Therapeutic areas › Oncology › Breast Cancer
Breast Cancer (19 companies)
Companies with an active program in Breast Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKTS | Aktis Oncology | Oncology | 1 | Phase 1 | 10 |
| ANIX | Anixa Biosciences | Oncology | 1 | Phase 1 | 3 |
| ARTV | Artiva Biotherapeutics | DermatologyImmunology+2 Rare | 1 | Phase 2 | 14 |
| ARVN | Arvinas | NeurologyOncology Rare | 1 | Approved | 12 |
| BCTX | BriaCell Therapeutics | Oncology | 3 | Phase 3 | 7 |
| BBOT | BridgeBio Oncology Therapeutics | Oncology | 1 | Phase 1 | 8 |
| CLRB | Cellectar Biosciences | Oncology | 1 | Phase 2 | 6 |
| CMPX | Compass Therapeutics | Oncology | 1 | Phase 2 | 9 |
| CYDY | CytoDyn | NeurologyOncology | 1 | Phase 2 | 3 |
| EIKN | Eikon Therapeutics | Oncology | 2 | Phase 2 | 13 |
| FHTX | Foghorn Therapeutics | Oncology | 1 | Phase 1 | 5 |
| GLSI | Greenwich LifeSciences | Oncology | 1 | Phase 3 | 1 |
| IBRX | ImmunityBio | Infectious DiseaseOncology | 1 | Approved | 16 |
| IMNM | Immunome | Oncology Rare | 1 | NDA Submitted | 9 |
| KAPA | Kairos Pharma | Oncology | 1 | Phase 2 | 9 |
| GLUE | Monte Rosa Therapeutics | CardiovascularDermatology+2 Rare | 1 | Phase 2 | 6 |
| PMVP | PMV Pharmaceuticals | Oncology | 1 | Phase 2 | 7 |
| RLAY | Relay Therapeutics | DermatologyOncology Rare | 1 | NDA Submitted | 4 |
| VIR | Vir Biotechnology | Infectious DiseaseOncology Rare | 1 | Phase 3 | 10 |
No companies match.